About Brawn Biotech
Brawn Biotech is a company based in Delhi (India) founded in 1986. Brawn Biotech offers products and services including Antibacterials, Cardiovasculars, and Antidiabetics. Brawn Biotech operates in a competitive market with competitors including AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
- Headquarter Delhi, India
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Brawn Biotech Limited
-
Annual Revenue
$1.58 M (USD)-18.07as on Mar 31, 2025
-
Net Profit
-$203.67 K (USD)-39.54as on Mar 31, 2025
-
EBITDA
-$207.41 K (USD)-16.67as on Mar 31, 2025
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Brawn Biotech
Brawn Biotech is a publicly listed company on the BSE with ticker symbol BRAWN in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Brawn Biotech
Brawn Biotech offers a comprehensive portfolio of products and services, including Antibacterials, Cardiovasculars, and Antidiabetics.
Medications for treating bacterial infections effectively.
Drugs for managing heart and blood vessel conditions.
Treatments for controlling blood sugar levels in diabetes.
Funding Insights of Brawn Biotech
Investments & Acquisitions by Brawn Biotech
Financial Statements - Brawn Biotech
Brawn Biotech Comparisons
Competitors of Brawn Biotech
Brawn Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| domain | founded_year | HQ Location |
India's leading healthcare products distribution platform
|
|
| domain | founded_year | HQ Location |
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
|
|
| domain | founded_year | HQ Location |
Provider of medical equipment, devices, and drugs distribution services
|
|
| domain | founded_year | HQ Location |
Serves as a distributor of a wide range of pharmaceutical drugs.
|
|
| domain | founded_year | HQ Location |
Distributor of pharmaceutical raw materials
|
Frequently Asked Questions about Brawn Biotech
Brawn Biotech was founded in 1986.
Brawn Biotech is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Annual revenue of Brawn Biotech is $1.58M as on Mar 31, 2025.
Brawn Biotech Ltd. was founded in 1986 and operates as a fully integrated healthcare company based in Delhi, India. Presence is maintained in both domestic and international markets, with pharmaceutical formulations provided across a broad range of product segments. Operations focus on the Indian pharmaceutical industry, where market share is targeted through established distribution networks in the healthcare sector.
Brawn Biotech's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.
Brawn Biotech offers Antibacterials, Cardiovasculars, and Antidiabetics.
Yes, Brawn Biotech is publicly traded on BSE under the ticker symbol BRAWN.
The ticker symbol of Brawn Biotech is BRAWN on BSE.